Collection of peripheral blood stem cells after a preceding autograft: Unfavorable effect of prior interferon-α therapy

Bone Marrow Transplantation

Volumn 24, Issue 1, 1999, Pages 13-17

  Singhal, S ^a   Mehta, J ^a   Desikan, K ^a   Siegel, D ^a   Singh, J ^a   Munshi, N ^a   Spoon, D ^a   Anaissie, E ^a   Ayers, D ^a   Barlogie, B ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Autologous peripheral blood stem cell transplantation; G CSF; Interferon ; Leukapheresis; Multiple myeloma; Relapse

Indexed keywords

ALPHA INTERFERON; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN;

ADULT; AGED; APHERESIS; ARTICLE; AUTOGRAFT; AUTOTRANSPLANTATION; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REMISSION; SALVAGE THERAPY; THROMBOCYTE COUNT;

EID: 0032764327     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701828     Document Type: Article

References (14)

1. Tricot G, Jagannath S, Vesole DH et al. Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy. Bone Marrow Transplant 1995; 16: 7-11.
2. Mehta J, Powles R, Treleaven J et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997; 19: 709-719.
3. Vesole DH, Tricot G, Jagannath S et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996; 88: 838-847.
4. Barlogie B, Jagannath S, Vesole DH et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-793.
5. Tricot G, Jagannath S, Vesole D et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
6. Singhal S, Mehta J, Hood S et al. Third transplants for myeloma relapsing after two prior autografts. Blood 1997; 90 (Suppl. 1): 547a (Abstr.).
7. Mehta J, Tricot G, Jagannath S et al. High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant. Bone Marrow Transplant 1997; 20: 113-116.
8. Lansdorp PM. Self-renewal of stem cells. Biol Blood Marrow Transplant 1997; 3: 171-178.
9. De Fabritiis P, Sandrelli A, Meloni G et al. Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transplant 1990; 6: 247-251.
10. Mehta J, Mijovic A, Powles R et al. Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia. Bone Marrow Transplant 1996; 17: 25-29.
11. Mehta J, Powles R, Singhal S et al. High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia. Leuk Lymphoma 1996; 23: 107-111.
12. Ramiah V, Powles R, Sumpter K et al. A randomised trial of short course consolidation chemotherapy (MRC UKALL X) following high dose chemotherapy in multiple myeloma. Blood 1997; 90 (Suppl. 1): 407b.
13. Desikan R, Siegel D, Passas A et al. DCEP consolidation after tandem autotransplants in (AT) in high risk multiple myeloma (MM) - improved prognosis compared to matched historical controls. Blood 1998; 92 (Suppl. 1): 660a.
14. Tallman MS, Rademaker AW, Jahnke L et al. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer. Bone Marrow Transplant 1997; 20: 721-729.